Neurology and Neurosurgery

Episodes 1-15 of 22

• 

  RestartResume

  Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers

  Medical Industry Feature

  Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Carolyn Clevenger, DNP

    Peer

  • 

    

    George Grossberg, MD

    Peer

• 

  RestartResume

  Managing NF1 PN with this First and Only FDA-Approved Treatment Option

  Medical Industry Feature

  Managing NF1 PN with this First and Only FDA-Approved Treatment Option

  • 

    Sandy Millman

    Peer

  • 

    

    Pinki Prasad, MD

    Peer

• 

  RestartResume

  Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)

  Medical Industry Feature

  Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)

  • 

    

    Gregory Cooper, MD, PhD

    Peer

• 

  RestartResume

  Patient-Centric Care for Managing Certain Manifestations of VHL Disease

  Medical Industry Feature

  Patient-Centric Care for Managing Certain Manifestations of VHL Disease

• 

  RestartResume

  Long-Term Subcutaneous Immunoglobulin (SCIg) in CIDP: The Maintenance Phase

  Medical Industry Feature

  Long-Term Subcutaneous Immunoglobulin (SCIg) in CIDP: The Maintenance Phase

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Karissa Gable, MD

    Peer

  • 

    Suraj Muley, MD

    Peer

• 

  RestartResume

  Managing MS: The Role of Immunoglobulins in the Immune System and Long-Term Safety Data for a B-Cell RMS Therapy

  Medical Industry Feature

  Managing MS: The Role of Immunoglobulins in the Immune System and Long-Term Safety Data for a B-Cell RMS Therapy

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Stephen Hauser, MD

    Peer

• 

  RestartResume

  Examining Maintenance Treatment Options in CIDP

  Medical Industry Feature

  Examining Maintenance Treatment Options in CIDP

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Karissa Gable, MD

    Peer

• 

  RestartResume

  The Gene Messenger: Advancing Neurological Gene Therapy

  Medical Industry Feature

  The Gene Messenger: Advancing Neurological Gene Therapy

  • 

    

    Michael Kaplitt, MD, PhD

    Peer

• 

  RestartResume

  The Inflection Point: When to Initiate Treatment for Parkinson's Disease (PD)–related Hallucinations and Delusions

  Medical Industry Feature

  The Inflection Point: When to Initiate Treatment for Parkinson's Disease (PD)–related Hallucinations and Delusions

  • 

    

    Stuart H. Isaacson, MD

    Peer

  • 

    Laxman Bahroo, MD

    Peer

  • 

    Craig Chepke, MD

    Peer

  • 

    Amita Patel, MD

    Peer

• 

  RestartResume

  The Network Effect: Analyzing Brain Structures to Treat Depression

  Medical Industry Feature

  The Network Effect: Analyzing Brain Structures to Treat Depression

  • 

    

    Conor Liston, MD, PhD

    Peer

• 

  RestartResume

  Advances in Acute Seizure Treatment Options

  Medical Industry Feature

  Advances in Acute Seizure Treatment Options

  • 

    

    Lawrence Hirsch, MD

    Peer

• 

  RestartResume

  Identifying Appropriate Patients for Acute Seizure Treatment

  Medical Industry Feature

  Identifying Appropriate Patients for Acute Seizure Treatment

  • 

    Sheryl Haut, MD

    Peer

• 

  RestartResume

  Empower Your Patients With a Seizure Action Plan

  Medical Industry Feature

  Empower Your Patients With a Seizure Action Plan

  • 

    

    Lawrence Hirsch, MD

    Peer

• 

  RestartResume

  Examining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs

  Medical Industry Feature

  Examining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs

  • 

    

    Charulatha P. Nagar, MD

    Peer

• 

  RestartResume

  Diving into a Treatment for Seizure Clusters Through Patient Case Studies

  Medical Industry Feature

  Diving into a Treatment for Seizure Clusters Through Patient Case Studies

  • 

    David Burdette, MD

    Peer

• 1
• 2
• Next